A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity

Clinical trial NCT07717814 · COMPLETED

Trial details

NCT number: NCT07717814
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2024-11-26
Primary completion: 2025-05-22
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.